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(Received for publication August 30, 1985) The synthesis of the orally absorbed 3-ethynylcephalosporin (1b) is described. In addition, the structure-activity relationships and oral absorption in rats of 7(3-[(Z)-2-(2-amino-4-thiazolyl)-2-carboxymethoxyiminoacetamido]cephalosporins (1) having various aliphatic hydrocarbon groups at the 3-position are discussed. Of these cephalosporins (1), 3-ethynylcephalosporin (1b) exhibited better activity against Staphylococcus aureus than the other cephalosporins (1a, 1c and 1d) and showed moderate oral absorption in rats.
During our extensive studies on the antibacterial activity and oral absorption of 719-[(Z)-2-(2-amino-4-thiazolyl)-2-carboxymethoxyiminoacetamido]cephalosporins1, 2) having various substituents at the 3-position of the cephem nucleus, we observed that compounds with relatively small substituents such as hydrogen, chloro, vinyl, methoxy, and methylthio exhibited higher oral absorptivity in rats.
In particular, FK0273,4) (1c)" having a vinyl group at the 3-position was found to be an orally active cephalosporin with almost the same broad antimicrobial activity as the parenteral cephalosporins containing the aminothiazole ring such as ceftizoxime, cefotaxime and cefmenoxime, except against Staphylococcus aureus. Consequently, we directed our research efforts towards synthesizing a new cephalosporin with a sterically small substituent at the 3-position, which might exhibit higher antibacterial activity, in particular against S. aureus, and even better oral absorption than the FK027) . Among possible structural changes, we were especially interested in preparing a new cephalosporin with a 3-ethynyl group, whose carbon-carbon bond length is shorter than that of the vinyl group (Fig. 1) .
Thus, we report the preparation of 3-ethynylcephalosporin (1b) and the structure-activity relationships and oral absorption in rats of a series of cephalosporins (1) having various aliphatic hydrocarbon substituents at the 3-position. butyllithium5) did not give the desired 3-ethynyl-2-cephem (3) but many unknown compounds. Therefore, we investigated an alternative approach. The 3-(2,2-dibromovinyl)-2-cephem (2) was oxidized with rn-chloroperbenzoic acid to yield the corresponding sulfoxide (4), which was treated with two equivalents of butyllithium to recover unchanged starting material (4) . Synthesis of the 3-ethynylcephem 1-oxide (5) was finally achieved by treatment of 4 with four equivalents of butyllithium (yield; 57.7%). The 3-ethynylcephem 1-oxide (5) was reduced with phosphorus trichloride (PC13) to afford the corresponding 3-ethynyl-3-cephem (6) , whose phenylacetyl side chain was removed with phosphorus pentachloride (PCl3) to give the 7-amino-3-ethynylcephem (7) . In Pathway B, the 7-formamido-3-(2,2-dibromovinyl)-2-cephem (9) was obtained from 2 by cleavage of the phenylacetyl side chain with PCI" followed by formylation with a mixture of formic acid and acetic anhydride. 9 was oxidized with m-chloroperbenzoic acid to afford the corresponding sulfoxide (10) , which on treatment with four equivalents of butyllithium at -70°C immediately followed by hydrolysis and then reduction with PC], gave a mixture of the corresponding 3-ethynyl-3- the 3-ethynyl-3-cephem (14) was effected with concentrated hydrochloric acid in methanol to yield the 7-amino-3-ethynylcephem (7).
Alternately, when the sulfoxide (10) was treated with three equivalents of butyllithium at -70°C and the reaction mixture kept at this temperature for 30 minutes before hydrolysis, a mixture of 3-ethynylcephem 1-oxide (11) and the starting material (10) (approximate ratio 1: 1) was obtained.
Treatment of the sulfoxide (10) with four equivalents of butyllithium by the same procedure afforded exclusively the corresponding 3-ethynylcephem 1-oxide (11) (yield; 98.5 %), which was then converted to the 3-ethynyl-3-cephem (14) by reduction with PCl3. On the basis of the above results, these reactions seem to involve the intermediates X and Y6~8).
In order to confirm the structure, the sulfoxide (10) Tables 1 and 2 .
Both methods leading to the 7-amino-3-ethynylcephem (7) appeared to be feasible, but the yields obtained via Pathway B turned out to be higher than those via Pathway A.
The cephalosporin (1b) was prepared by the two paihways outlined in Scheme 2. According to Pathway C, 8 was acylated with an activated acid which was obtained by treatment of the acid (18) with Vilsmeier reagent prepared from phosphoryl chloride and N,N-dimethylformamide, followed by oxidation to give the sulfoxide (20). 20 was successfully converted to the corresponding 3-ethynyl- (7) with the activated acid of 18. Cephalosporin (1b) was obtained by deformylation of 22 with concentrated hydrochloric acid, followed by deprotection of the diphenylmethyl groups with TFA and anisole.
Antibacterial Activity and Oral Absorption
The minimum inhibitory concentrations (MICs) of the cephalosporins (1) having various aliphatic Against Gram-negative bacteria, the activity of FK027 (1c) was highest while the 3-ethynylcephalosporin (lb) showed slightly reduced activity. The cephalosporins (1a and 1d) with the alkyl chains were found to be 8~16 times less active against Proteus vulgaris 1 than FK027 (1c).
The urinary excretion of the cephalosporins (1) after oral administration (100 mg/kg) to rats can be seen in Table 4 . The 3-ethynylcephalosporin (1b) was well absorbed, but its urinary recovery was less than that of FK027 (lc). Consequently, we could not find a correlation between the size of the substituent at the 3-position and the oral absorptivity in rats.
In this series, the influence of various substituents at the 3-position of the cephem nucleus on the antibacterial activity and oral absorption in rats was investigated by keeping the 7-acyl chain constant as the (Z)-2-(2-amino-4-thiazolyl)-2-carboxymethoxyiminoacetyl radical. The cephalosporins with the 2,2-dihalovinyl groups2) and the ethynyl group (1b) showed improved activity against S. aureus but reduced urinary recovery after oral administration to rats in comparison with FK027 (1c). FK027
(1c) with the vinyl group at the 3-position was found to be a cephalosporin exhibiting not only higher activity against Gram-negative bacteria but also better oral absorptivity in rats.
Experimental
MP were determined using a Thomas-Hoover capillary melting point apparatus and are uncorrected. NMR spectra were recorded at 60 MHz on a JNM-PMX 60 NMR spectrometer and at 100 MHz on a Jeol-MH 100 NMR spectrometer using Me4Si as an internal standard. IR spectra were taken on a Hitachi 260-10 spectrophotometer or a Shimadzu IR-420 spectrophotometer.
Antibiotic Susceptibility All in vitro antibacterial activity data are given as the minimum inhibitory concentration (MIC) in pg/ml. MICs were determined by the agar dilution method using heart infusion agar (Difco) after incubation at 37°C for 20 hours with an inoculum size of about 101 cfu/ml. Urinary Recovery Sprague Dawley rats were fasted overnight and orally dosed with 100 mg/kg of the test drugs. Urine samples were collected for 24 hours after dosing. The samples were assayed by a disc-agar diffusion method using Escherichia cola NIHJ JC-2 or E. coli ATCC 33546 as the test organism and nutrient agar (Difco) as the test medium.
General Preparation of 7
Pathway A: Diphenylmethyl 7(3-Phenylacetamido-3-ethynyl-3-cephem-4-carboxylate 1-Oxide (5): To a soln of diphenylmethyl 713-phenylacetamido-3-(2,2-dibromovinyl)-3-cephem-4-carboxylate 1-oxide3) (4) (0.34 g, 0.5 mmol) in THE (20 ml) was added a soln of butyllithium (1.2 ml of 1.65 M soln in n-hexane, 2 mmol) at -70--60°C under a nitrogen atm. After being stirred for 30 minutes at the same temp, the reaction mixture was diluted with EtOAc (20 ml) and acidified with 10% HCl. The separated organic layer was washed with H2O and brine, and dried (MgSO4). The solvent was evaporated to Diphenylmethyl 7j3-Amino-3-ethynyl-3-cephem-4-carboxylate Hydrochloride (7): Pyridine (0.05 ml, 0.6 mmol) was added to a suspension of PCl5 (0.125 g, 0.6 mmol) in dichlo romethane (1 ml) at -10°C, and the mixture was stirred at -15~-5°C
for 30 minutes. 6 (0.153 g, 0.3 mmol) was added to the above mixture at -10°C and the reaction mixture was stirred under ice-cooling for 1 hour. Then, MeOH (0.2 ml) was added to the reaction mixture at -20°C and the resulting soln was stirred under ice-cooling for 1 hour. H2O (0.2 ml) was added to the above mixture under icecooling. The resulting mixture was stirred for 30 minutes at the same temp, and then diluted with diisopropyl ether. Diphenylmethyl 7(3-Formamido-3-(2,2-dibromovinyl)-2-cephem-4-carboxylate (9): 8 (5 g, 8.5 mmol) was added to a mixture of EtOAc (50 ml), THE (50 ml) and H,O (100 ml), and the mixture was adjusted to pH 7 with satd sodium bicarbonate soln. The separated organic layer was washed with brine, and dried (MgSO4). The soln was evaporated in vacuo and the residue was dissolved in dichloromethane (50 ml). On the other hand, a mixture of acetic anhydride (3.2 ml, 34 mmol) and formic acid (1.29 ml, 34 mmol) was stirred at 40~45°C for 30 minutes. This soln was added to the dichloromethane soln obtained above under ice-cooling, and the resultant mixture was stirred at the same temp for 1 hour. The reaction mixture was poured into a mixture of EtOAc and H2O. The separated organic layer was washed with satd sodium bicarbonate soln and brine, and dried (MgSO4). Diphenylmethyl 7~-Formamido-3-(2,2-dibromovinyl)-3-cephem-4-carboxylate 1-Oxide (10): To a mixture of 9 (4.2 g, 7.26 mmol) in EtOAc (42 ml) was added a soln of m-chloroperbenzoic acid (1.72 g, 10 mmol) in EtOAc (8 ml) at -20~ -10°C and the resultant mixture was stirred at -10°C for 45 minutes. The precipitate was collected by filtration to afford 1.9 g (43.7 %) of 10: IR (Nujol) 3270, 1790, 1710, 1655 cm-1; 1H NMR (DMSO-d,) 3 8.47 (1H, d, 8.20 (IH, s), 7.777.20 (IIH, m), 6.98 (1H, s), 6.12 (1H, dd, 8 Hz), 5.05 (IH, d, J=5 Hz), 4.17 ~ 3.67 (2H, m) . : 11 was obtained (98.5%) from 10 by a similar procedure as described for the prepn of 5: IR (Nujol) 1790, 1720, 1660 cm-1; 1H NMR (DMSO-d,) 6 8.48 (1H, d, J=8 Hz), 8.15 (1H, s), 7.787.12 (IOH, m), 6.97 (1 H, s), 6.03 (1H, dd, J=5, 8 Hz), 5.02 (1H, d, J=5 Hz), 4.72 (1H, s), 4.08~3.67 (2H, m) . : 14 was obtained (55.5%) from 11 by a similar procedure as described for the prepn of 6: mp 156~ 160°C;
Anal Calcd for C13H18N2O4 •1/4H2O: C 65.31, H 4.41, N 6.62, S 7.58. Found: C 65.59, H 4.15, N 6.26, S 7.81 10 (54 g, 0. 091 mol) in THE (1.5 liters) was added a soln of butyllithium (235 ml of 1.55 M soln in n-hexane, 0.364 mol) at -70~ -60°C under a nitrogen atm. Immediately after the addition, the reaction mixture was diluted with EtOAc (1 liter) and acidified with 10% HCl. The separated organic layer was washed with H2O and brine, and dried (MgSO4). The solvent was evaporated and the residue was dissolved in DMF (300 ml). To the DMF soln was added PCl3 (15.1 ml, 0.173 mol) at -30-20'C . The resultant mixture was stirred at the same temp for 30 minutes. The reaction mixture was poured into a mixture of EtOAc and H2O, and the separated organic layer was washed with satd sodium bicarbonate soln and brine, and dried (MgSO4). The soln was evaporated to yield a brownish powder, which was recrystallized from dichloromethane -diisopropyl ether to afford 20.03 g (55.5%) of 14. The filtrate was purified by column chromatography on silica gel, eluting with dichloromethane -EtOAc (10: 1) to give 0.61 g (1.4%) of 13; mp 139~ 142°C.
Diphenylmethyl 714-Amino-3-ethynyl-3-cephem-4-carboxylate Hydrochloride (7): Concd HC1 (1.6 ml, 18.12 mmol) was added to a suspension of 14 (3 g, 7. 17 mmol) in McOH (15 ml) at room temp for 2 hours. The reaction mixture was poured into ether (100 ml) and the resulting precipitate was collected by filtration to afford 2.79 g (99.7 %) of 7.
Diphenylmethyl 7/9-Formamido-3-(2,2-dibromovinyl)-3-cephem-4-carboxylate (12) 12 was obtained (73.5 %) from 10 by a similar procedure as described for the prepn of 6; mp 119~124°C.
Anal 7P-Formamido-3-(2,2-dibromovinyl)-3-cephem-4-carboxylic Acid (15) TFA (10 ml) was added to a mixture of 12 (10 g, 17.3 mmol) and anisole (10 ml) in dichloromethane (30 ml) under ice-cooling, and the reaction mixture was stirred at the same temp for 30 minutes. The resultant mixture was poured into diisopropyl ether, and the precipitate was collected by filtration. The above precipitate was added to a mixture of EtOAc and H2O, and the mixture was adjusted to pH 7.0 with satd sodium bicarbonate soln. The separated aq layer was acidified to pH 2 with 10% HCl, and extracted with EtOAc. The EtOAc soln was washed with brine, and dried (MgSO4). The soln was evaporated in vacuo to afford 7.15 g (73.5 %) of 15.
714-Formamido-3-[(E)-2-monobromovinyl]-3-cephem-4-carboxylic
Acid (16) 16 was obtained (87.1 %) from 13 by a similar procedure as described for the prepn of 15; mp 122~ 126°C. 17 was obtained (34.9 %) from 14 by a similar procedure as described for the prepn of 15; mp 145 ~ 153°C.
713-Formamido
1H NMR and IR data of compounds (12~ 17) were listed in Tables I and 2 .
General Preparation of lb Pathway C: Diphenylmethyl 714-[(Z)-2-Diphenylmethoxycarbonylmethoxyimino-2-(2-frmamido -4-thiazolyl)-acetamido]-3-(2,2-dibromovinyl)-2-cephem-4-carboxylate (19): To a soln of DMF (1.89 ml, 24.4 mmol) in THE (72 ml) was added phosphoryl chloride (2.25 ml, 24.4 mmol) under ice-cooling , and the mixture was stirred at the same temp for 30 minutes to prepare the Vilsmeier reagent. To the above mixture was added the N-formyl acid3) (18) (8.96 g, 20.4 mmol) under ice-cooling , and the resultant mixture was stirred at the same temp for 30 minutes to produce an activated acid soln of 18. To a soln of the 7p-amino-3-ethynylcephem (7) (10 g, 18.2 mmol) and N-(trimethylsilyl)acetamide (13 .4 g, 102 mmol) in EtOAc (100 ml) was added the above activated acid soln at -30°C, and the reaction mixture was stirred at -20~ -10°C for 30 minutes. The reaction mixture was poured into a mixture of EtOAc and H2O. The separated organic layer was washed with satd sodium bicarbonate soln and brine, and dried (MgSO4). The soln was evaporated in vacuo to afford 15.3 g (92.7%) of 19: IR (Nujol) 1760, 1740, 1680 cm-'; 'H NMR (DMSO-d6) 6 9.77 (1H, d, J=8 Hz), 8.51 (1H, s), 
